London, UK -- (MARKET WIRE) -- November 20, 2006 --
For Immediate Release 20 November 2006
SkyePharma PLC
SKYEPHARMA TO PRESENT AT 18th ANNUAL PIPER JAFFRAY
HEALTH CARE CONFERENCE
LONDON, UK, 20 November 2006 -- SkyePharma PLC (Nasdaq: SKYE; LSE: SKP)
announces today that the Company's Chief Executive Officer, Frank Condella, will make a presentation at the 18th Annual Piper Jaffray Health Care Conference at the Pierre Hotel, New York. Mr. Condella will deliver his presentation on Thursday, November 30, 2006 at 3.30 p.m. ET (8.30 p.m. GMT). Investors may access a live webcast of the presentation at
www.skyepharma.com under the Investor Relations tab. The presentation will be archived for 30 days.
For further information please contact:
SkyePharma PLC +44 207 491 1777
Frank Condella, Chief Executive Officer
Ken Cunningham, Chief Operating Officer
Buchanan Communications +44 207 466 5000
Tim Anderson / Mark Court / Rebecca Skye Dietrich
The Trout Group + 1 617 583 1308
Seth Lewis
About SkyePharma PLC
SkyePharma PLC develops pharmaceutical products benefiting from world-leading drug delivery technologies that provide easier-to-use and more effective drug formulations. There are now eleven approved products incorporating SkyePharma's technologies in the areas of oral, injectable, inhaled and topical delivery, supported by advanced solubilisation capabilities. For more information, visit
www.skyepharma.com.
This information is provided by RNS
The company news service from the London Stock Exchange